Multivariate logistic regression analysis of factors associated with complete response (CR) based on interaction with treatment type demonstrated a trend that favored RT+5FU/Cap+Ox recipients over RT+5FU/Cap patients with respect to CMS4 and overexpression of stromal signatures. However, RT+5FU/Cap+Ox recipients were less likely to achieve CR with increasing tumor purity and RSS scores. *OR is reported as “OR per SD” to account for diverse distributions. LateTA score, late transient-amplifying score; Ma-TBRS, macrophage TGFβ response signature.
No takes yet. Share an insight, caveat, or question.
Mahmood et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: